Literature DB >> 7417838

Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.

M Rossor, J Fahrenkrug, P Emson, C Mountjoy, L Iversen, M Roth.   

Abstract

Post-mortem brain tissue from 7 patients who died with a diagnosis of senile dementia of Alzheimer type (SDAT) was compared with tissue obtained from 7 control patients at routine post mortem. A significant fall in choline acetyltransferase (ChAT) activity was apparent in the cerebral cortex of the SDAT cases which was maximal in the temporal lobe. The fall in ChAT activity was not accompanied by changes in cortical vasoactive intestinal polypeptide (VIP) measured by radioimmunoassay.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7417838     DOI: 10.1016/0006-8993(80)90795-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Alzheimer's disease: a correlative study.

Authors:  D Neary; J S Snowden; D M Mann; D M Bowen; N R Sims; B Northen; P O Yates; A N Davison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

2.  Comparison of DSIP- (delta sleep-inducing peptide) and P-DSIP-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type, multi-infarct syndrome, communicating hydrocephalus and Parkinson's disease.

Authors:  A Ernst; H Cramer; D Strubel; F Kuntzmann; G A Schoenenberger
Journal:  J Neurol       Date:  1987-10       Impact factor: 4.849

Review 3.  Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

Authors:  A Leake; I N Ferrier
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

4.  Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease.

Authors:  S Jegou; F Javoy-Agid; C Delbende; M Ruberg; H Vaudry; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

Review 5.  Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment.

Authors:  C G Gottfries
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.

Authors:  K Fujiyoshi; H Suga; K Okamoto; S Nakamura; M Kameyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

7.  Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core.

Authors:  M N Rossor
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12

8.  The noradrenergic system in Alzheimer and multi-infarct dementias.

Authors:  D M Mann; P O Yates; J Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

9.  Confusion, dementia and anticholinergics in Parkinson's disease.

Authors:  Y de Smet; M Ruberg; M Serdaru; B Dubois; F Lhermitte; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-12       Impact factor: 10.154

10.  Neuropsychological syndromes in presenile dementia due to cerebral atrophy.

Authors:  D Neary; J S Snowden; D M Bowen; N R Sims; D M Mann; J S Benton; B Northen; P O Yates; A N Davison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.